AML maintenance: It’s now a thing
Maintenance is a important component of therapy for acute lymphoblastic leukemia, but it’s still a relatively new concept in the treat of patients with acute myeloid leukemia (AML).
Latest News
September 24, 2020
‘Paradigm shift’ in gastric junction cancers with nivolumab
September 24, 2020
ESMO: European Society for Medical Oncology
MDedge Hematology and Oncology
September 24, 2020
J&J’s one-shot COVID-19 vaccine advances to phase 3 testing
September 24, 2020
MDedge Hematology and Oncology
September 24, 2020
Hepatocellular carcinoma shows risk factor shift
September 24, 2020
Digestive Diseases: New Advances
MDedge Hematology and Oncology
B&C Podcast Shownotes
Studying cancer patients with COVID-19: NCCAPS and CCC19
How do patients fare when they have cancer and COVID-19? Researchers developed the COVID-19 and Cancer Consortium (CCC19) and the National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS) to gain some insight. In this episode, Dr. Brian Rini explains how NCCAPS and CCC19 work and discusses findings from CCC19 that were presented at the ESMO Virtual Congress 2020.
Conference Coverage
September 24, 2020
‘Paradigm shift’ in gastric junction cancers with nivolumab
September 24, 2020
ESMO: European Society for Medical Oncology
MDedge Hematology and Oncology
September 24, 2020
Hepatocellular carcinoma shows risk factor shift
September 24, 2020
Digestive Diseases: New Advances
MDedge Hematology and Oncology
September 24, 2020
New first-line standard of care for esophageal cancer?
September 24, 2020
ESMO: European Society for Medical Oncology
MDedge Hematology and Oncology
COVID-19: Heme/Onc
September 20, 2020
Survey quantifies COVID-19’s impact on oncology
September 20, 2020
ESMO: European Society for Medical Oncology
MDedge Hematology and Oncology
September 16, 2020
COVID-19 prompts ‘democratization’ of cancer trials
September 16, 2020
AACR: COVID-19 and Cancer
MDedge Hematology and Oncology
September 16, 2020
COVID-19 and Blood Clots: Inside the Battle to Save Patients
September 16, 2020
MDedge Hematology and Oncology
August 31, 2020
VTE, sepsis risk increased among COVID-19 patients with cancer
August 31, 2020
AACR: COVID-19 and Cancer
MDedge Hematology and Oncology
News from the FDA/CDC
September 9, 2020
Atezolizumab TNBC indication ‘in jeopardy’ because of phase 3 results
September 9, 2020
MDedge Hematology and Oncology
September 8, 2020
Pralsetinib: Second drug for RET+ NSCLC approved in U.S.
September 8, 2020
MDedge Hematology and Oncology
August 31, 2020
FDA expands remdesivir use for all COVID-19 hospitalized patients
August 31, 2020
MDedge Hematology and Oncology
Policy & Practice
September 23, 2020
Smart home devices – promises and pitfalls
September 23, 2020
MDedge Hematology and Oncology
September 22, 2020
More female specialists, but gender gap persists in pay, survey finds
September 22, 2020
MDedge Hematology and Oncology
September 21, 2020
Without Ginsburg, judicial threats to the ACA, reproductive rights heighten
September 21, 2020
MDedge Hematology and Oncology
September 21, 2020
Physician reimbursement 2021: Who are the big winners?
September 21, 2020
MDedge Hematology and Oncology
Opinion
September 23, 2020
Smart home devices – promises and pitfalls
September 23, 2020
MDedge Hematology and Oncology
September 21, 2020
Without Ginsburg, judicial threats to the ACA, reproductive rights heighten
September 21, 2020
MDedge Hematology and Oncology
September 21, 2020
Physician reimbursement 2021: Who are the big winners?
September 21, 2020
MDedge Hematology and Oncology
September 17, 2020
2020-2021 respiratory viral season: Onset, presentations, and testing likely to differ in pandemic
September 17, 2020
MDedge Hematology and Oncology